PLoS ONE (Jan 2014)

Activated peritoneal cavity B-1a cells possess regulatory B cell properties.

  • Bram Margry,
  • Saskia C W Kersemakers,
  • Aad Hoek,
  • Ger J A Arkesteijn,
  • Willemien H Wieland,
  • Willem van Eden,
  • Femke Broere

DOI
https://doi.org/10.1371/journal.pone.0088869
Journal volume & issue
Vol. 9, no. 2
p. e88869

Abstract

Read online

Previous studies have suggested that murine peritoneal cavity-derived B-1a cells possess similarities with described regulatory B cell subsets. The aim of the current study was to examine the potential immunoregulatory function of peritoneal cavity-derived B(-1a) cells. In vitro activation of peritoneal cavity-derived B- and B-1a cells shows that activation of these B cells with anti-CD40 and LPS induces these cells to secrete more IL-10, IL-6 and IgM as compared to splenic B cells. In a suppression assay, CD40/TLR4-activated peritoneal cavity B cells possess regulatory B cell functions as they inhibit the capacity of CD4(+) T cells to produce both tumor necrosis factor-α and interferon-γ. Splenic B cells did not show this, whereas non-activated peritoneal cavity B cells augmented the capacity of CD4(+) T cells to produce tumor necrosis factor-α, while the ability to produce interferon-γ was not altered. The current paper compares splenic B cells to peritoneal cavity B(-1a) cells in an in vitro activation- and an suppression-assay and concludes that peritoneal cavity B(-1a) cells possess properties that appear similar to splenic autoimmune-suppressive regulatory B cell subsets described in the literature.